China Resources Pharmaceutical Group Limited Share Price
Stocks
3320
HK0000311099
Pharmaceuticals
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.430 HKD | +2.78% |
|
-1.34% | -0.45% |
| 01/06 | China Resources Pharma Unit Gets China Acceptance for 5 Billion Yuan Bond Issue; Shares Climb 3% | MT |
| 28/04 | China Resources Pharmaceutical Unit Sells 1.4 Billion Yuan Bonds | MT |
| Market Cap | 2.71TCr 345.29Cr 302.75Cr 279.07Cr 261.27Cr 489.92Cr 33TCr 500.09Cr 3.35TCr 1.3TCr 16TCr 1.3TCr 1.27TCr 56TCr | P/E 2026 * |
5.5x | P/E 2027 * | 5.14x |
|---|---|---|---|---|---|
| Enterprise Value | 8.04TCr 1.03TCr 899.28Cr 828.93Cr 776.05Cr 1.46TCr 97TCr 1.49TCr 9.96TCr 3.86TCr 48TCr 3.85TCr 3.77TCr 1,65800Cr | EV / Sales 2026 * |
0.25x | EV / Sales 2027 * | 0.22x |
| Free-Float |
28.62% | Yield 2026 * |
4.77% | Yield 2027 * | 5.2% |
| 1 day | +2.78% | ||
| 1 week | -1.34% | ||
| Current month | -5.14% | ||
| 1 month | -5.14% | ||
| 3 months | -22.28% | ||
| 6 months | -2.21% | ||
| Current year | -0.45% |
| 1 week | 4.24 |  | 4.54 |
| 1 month | 4.24 | | 4.98 |
| Current year | 4.24 | | 6.53 |
| 1 year | 4.24 | | 6.53 |
| 3 years | 4.24 | | 7.11 |
| 5 years | 3.18 | | 8.13 |
| 10 years | 3.18 | | 13.16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jie Cheng
PSD | President | 47 | 26/08/2025 |
Rong Hui Deng
DFI | Director of Finance/CFO | 54 | 13/06/2023 |
Wing Yi Wan
SEC | Corporate Secretary | - | 15/12/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Ting Mei Fu
BRD | Director/Board Member | 59 | 01/06/2016 |
Ke Jian Zhang
BRD | Director/Board Member | 70 | 20/06/2016 |
Xiao Song Bai
CHM | Chairman | 54 | 29/08/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01/20/01 | Other | Chief Executive Officer | 2,00,000 | 0.0032% | ||
| 31/20/31 | Other | Chief Executive Officer | 1,00,000 | 0.0016% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.78% | -1.34% | -13.48% | -33.78% | 345.29Cr | |
| +7.13% | +9.97% | +55.80% | +163.38% | 1,07700Cr | |
| +3.99% | +11.50% | +67.09% | +56.27% | 61TCr | |
| +4.20% | +17.03% | +38.97% | +91.19% | 45TCr | |
| +0.99% | +4.85% | +28.17% | +22.04% | 33TCr | |
| +1.82% | +8.19% | +40.04% | +27.45% | 29TCr | |
| +0.22% | +6.75% | +31.30% | +42.64% | 29TCr | |
| +0.73% | +8.53% | -27.33% | -40.29% | 21TCr | |
| +1.56% | +6.14% | +29.30% | +61.91% | 19TCr | |
| +3.26% | +3.33% | +15.55% | +67.87% | 16TCr | |
| Average | +2.67% | +7.21% | +26.54% | +45.87% | 36.2TCr | |
| Weighted average by Cap. | +3.85% | +9.64% | +41.70% | +80.91% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 32TCr 4.14TCr 3.63TCr 3.35TCr 3.13TCr 5.88TCr 3,90600Cr 6TCr 40TCr 16TCr 1,93000Cr 16TCr 15TCr 6,69400Cr | 34TCr 4.35TCr 3.82TCr 3.52TCr 3.29TCr 6.18TCr 4,10600Cr 6.3TCr 42TCr 16TCr 2,02900Cr 16TCr 16TCr 7,03700Cr |
| Net income | 482.57Cr 62Cr 54Cr 50Cr 47Cr 87Cr 5.8TCr 89Cr 597.77Cr 231.31Cr 2.87TCr 231.07Cr 226.03Cr 9.95TCr | 522.18Cr 67Cr 58Cr 54Cr 50Cr 94Cr 6.28TCr 96Cr 646.84Cr 250.29Cr 3.1TCr 250.04Cr 244.58Cr 11TCr |
| Net Debt | 5.34TCr 680.35Cr 596.53Cr 549.86Cr 514.79Cr 965.31Cr 64TCr 985.35Cr 6.61TCr 2.56TCr 32TCr 2.55TCr 2.5TCr 1,10000Cr | 4.8TCr 611.58Cr 536.23Cr 494.28Cr 462.75Cr 867.73Cr 58TCr 885.75Cr 5.94TCr 2.3TCr 29TCr 2.3TCr 2.25TCr 99TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/26/29 | HK$4.430 | +2.78% | 59,85,000 |
| 26/26/26 | HK$4.310 | -2.71% | 1,13,98,225 |
| 25/26/25 | HK$4.430 | -0.23% | 48,05,191 |
| 24/26/24 | HK$4.440 | -1.11% | 58,00,629 |
| 23/26/23 | HK$4.490 | 0.00% | 73,91,500 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 3320 Stock
Select your edition
All financial news and data tailored to specific country editions
